|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 85 CHF | -1.73% |
|
-1.59% | +0.15% |
| 07:28am | Novartis reports positive interim results for Fabhalta | CF |
| 05:26am | Novartis' Investigational Kidney Disease Drug Shows Reduced Disease Marker in Late-stage Trial | MT |
Health-care companies fell after mixed earnings results.
Shares of health-care conglomerate Johnson & Johnson rose after strong sales growth from pharmaceuticals lifted revenue in the latest quarter.
Shares of Swiss drugmaker Novartis fell after it reported earnings shy of some investors' expectations.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
01-26-21 1722ET
| 1st Jan change | Capi. | |
|---|---|---|
| +0.15% | 207B | |
| +28.21% | 676B | |
| +24.27% | 559B | |
| -7.49% | 356B | |
| +15.10% | 320B | |
| +5.31% | 286B | |
| +2.62% | 213B | |
| -9.41% | 199B | |
| -7.98% | 142B | |
| -3.31% | 116B |
NOVARTIS AG 
